SEC

A new fund awaiting SEC approval seeks “to address the concerns of vegans, animal lovers and environmentalists.”

Dick Lampen says the SEC charges against Dr. Phillip Frost, the firm’s primary shareholder, won’t affect its “significant” other resources.

The scheme involved paying cash kickbacks to a former Barclays and Stifel advisor who worked on the wealth syndicate desk.

While the IBD advocacy organization supports the proposal’s approach, key questions loom over the timeline and makeup of the potential regulation.

The firm is the first to be censured for violating the Identify Theft Red Flags rule.

John Gregory Schmidt allegedly devised a 14-year scheme that straddled his time with Stifel and Wells Fargo.

NAPFA’s chairman sees an “untapped market” opening up.

Under SEC rules, an advisor was statutorily disqualified after driving under the influence. Can he ever register with a brokerage again?

Observers expect only modest changes from comment letters, and look ahead to a vote to enact new advisor and broker regulations.

Dr. Phillip Frost, the principal shareholder of the IBD network’s parent firm, has stepped down, giving way to CEO Richard Lampen.

High-yield notes offering 10% to 18% in annual returns turned out far less lucrative than promised.

Agency also fines firm president Peter Mallouk for not reporting family accounts.

The advisor allegedly sold $13 million worth of high-risk securities without disclosing that she earned commissions of up to 18%.

Regulators in Massachusetts launched a “sweep” of more than 60 firms that sold nearly $1.3 billion in limited partnerships sponsored by GPB Capital.

The IBD’s advisors did not understand investments they sold to clients, the SEC says.

Lehman Brothers had collapsed. Panic, instability and a recession followed. Ten years later, the lessons from that era echo even more resoundingly.

The agency says the biotech magnate and nine others made $27 million pumping up penny stocks.

The firm allegedly encouraged clients to use an affiliated investment advisor, and benefitted from the fees it charged them.

The SEC says the 33% owner of the parent of the IBD network participated in unlawful microcap stock sales resulting in “virtually worthless” investments.